Moderna, Inc. (NASDAQ: MRNA), a pioneer in mRNA-based vaccine technology, has made significant strides in the biotech industry, most notably through its critical role in addressing the COVID-19 pandemic. As of mid-2023, Moderna's market cap ranks it outside of the top 5 biotech companies globally.
This question asks: Will Moderna ascend to be one of the top 5 biotech companies globally by market capitalization on or before December 31, 2028?
| Indicator | Value |
|---|---|
| Stars | ★★★☆☆ |
| Platform | Metaculus |
| Number of forecasts | 25 |
Moderna, Inc. (NASDAQ: MRNA), a pioneer in mRNA-based vaccine technology, has made significant strides in the biotech industry, most notably through its critical role in addressing the COVID-19 pandemic. As of mid-2023, Moderna's market cap ranks it...